SMTL ID : 4xuf.2 (1 other biounit)

Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

monomer

Ligands

1 x P30: 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl}phenyl)urea(Non-covalent)

P30.1: 18 residues within 4Å: Chain A: L.17, V.25, A.43, K.45, E.62, M.65, M.66, I.75, V.76, Y.94, C.95, C.96, G.98, H.159, L.168, C.178, D.179, F.180 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.17, A:L.17, A:V.25, A:I.75, A:D.179 Hydrogen bonds: A:K.45, A:K.45, A:E.62, A:D.179 pi-Stacking: A:F.180

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zorn, J.A. et al., Crystal Structure of the FLT3 Kinase Domain Bound to the Inhibitor Quizartinib (AC220). Plos One (2015)

Release Date

2015-04-15

Peptides

Receptor-type tyrosine-protein kinase FLT3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Receptor-type tyrosine-protein kinase FLT3

Related Entries With Identical Sequence